Notably, we find that XP and XP/CS disease mutations cluster at key interfaces of PInC’s dynamic communities, impacting NER protein stability, functional dynamics, DNA binding, nuclease licensing, and/or community integrity. This evidence concerns the gene NR1H2 and xeroderma pigmentosum.